NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,350,625 | -44.6% | 812,500 | -49.2% | 0.58% | -36.3% |
| Q2 2023 | $67,472,000 | +36.9% | 1,600,000 | -15.3% | 0.92% | +25.2% |
| Q1 2023 | $49,281,088 | +6.4% | 1,888,888 | +21.4% | 0.73% | +5.6% |
| Q4 2022 | $46,324,428 | +127.1% | 1,555,555 | +48.2% | 0.69% | +83.6% |
| Q3 2022 | $20,402,000 | +43.4% | 1,049,471 | 0.0% | 0.38% | +34.2% |
| Q2 2022 | $14,231,000 | -2.4% | 1,049,471 | 0.0% | 0.28% | +5.6% |
| Q1 2022 | $14,577,000 | -20.9% | 1,049,471 | -4.8% | 0.27% | -15.3% |
| Q4 2021 | $18,431,000 | -17.3% | 1,102,671 | -12.3% | 0.31% | -10.3% |
| Q3 2021 | $22,288,000 | – | 1,257,671 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |